1. HBW Insight

CIR’s Ginkgo Biloba Review Illustrates Growing Botanical Challenges

 
• By Ryan Nelson

The Cosmetic Ingredient Review Expert Panel issued a tentative insufficient data report for Ginkgo biloba-derived ingredients at its March 5-6 meeting. The panel’s struggle to map available ingredient information and toxicity data to specific uses in the cosmetics sector signals botanical review challenges that are likely to become only more frequent.

RS1803_Medicinal Leaves_ 661201579_1200.jpg

Difficulties faced by the Cosmetic Ingredient Review Expert Panel in assessing the safety of Ginkgo biloba-derived ingredients may be just the tip of the iceberg in an increasingly “natural” industry scrambling to keep up with consumer demand.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

More from HBW Insight

Opella Goes Solo Promising To ‘Redefine The Future Of Self-Care’

 
• By Tom Gallen

Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.

US Tariffs Pose ‘Existential Threat’ To EU Medical Devices Industry

 
• By David Ridley

AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.

US Fragrance Firms Should Identify Domestic, Non-Tariff Sources Now – Fragrance House CEO

Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.